ducovest

KMB:NYE-Kimberly-Clark Corporation (USD)

COMMON STOCK | Household & Personal Products |

Last Closing

USD 140.26

Change

+1.29 (+0.93)%

Market Cap

USD 44.91B

Volume

2.32M

Analyst Target

USD 159.17
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names. Its Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The company's K-C Professional segment offers wipers, tissues, towels, apparel, personal protective equipment, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. It also sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to distributors, manufacturing, lodging, office building, food service, and public facilities, as well as through e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Company Website : https://www.kimberly-clark.com

Currency: USD

Country : USA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-21 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap
UL Unilever PLC ADR

+0.59 (+1.06%)

 USD 138.03B
CHD Church & Dwight Company Inc

+0.90 (+0.86%)

 USD 26.34B
CLX The Clorox Company

+4.18 (+2.73%)

 USD 18.28B
HIMS Hims Hers Health Inc

-17.13 (-25.79%)

 USD 7.42B
COTY Coty Inc

+0.06 (+1.06%)

 USD 5.01B
ELF ELF Beauty Inc

+3.81 (+5.36%)

 USD 4.12B
SPB Spectrum Brands Holdings Inc

+0.10 (+0.13%)

 USD 2.06B
EPC Edgewell Personal Care Co

+0.33 (+1.08%)

 USD 1.54B
PZC PIMCO California Municipal Inc..

N/A

 USD 0.63B
YSG Yatsen Holding

+0.02 (+0.52%)

 USD 0.32B

ETFs Containing KMB

XDG6:XETRA 4.71 % 0.00 %

N/A

 N/A
KNGS 4.29 % 0.00 %

N/A

 N/A
XDGI:XETRA 3.25 % 0.00 %

N/A

 N/A
RUD:CA RBC Quant US Dividend Lea.. 3.14 % 0.43 %

-0.29 (-0.90%)

 CAD 0.73B
SHRY First Trust Bloomberg Sha.. 3.07 % 0.00 %

-0.44 (-0.90%)

 USD 0.02B
RSPS Invesco S&P 500 Equal Wei.. 2.73 % 0.00 %

+0.50 (+-0.90%)

 USD 0.26B
CAPS:LSE First Trust Capital Stren.. 2.16 % 0.00 %

+5.00 (+-0.90%)

 N/A
UGDV:LSE SPDR® S&P® U.S. Dividen.. 2.12 % 0.00 %

+0.05 (+-0.90%)

 N/A
UPGD Invesco Exchange-Traded F.. 2.11 % 0.00 %

-0.66 (-0.90%)

 N/A
SNPD DBX ETF Trust - Xtrackers.. 2.10 % 0.00 %

-0.02 (-0.90%)

 N/A
FLXX:SW Franklin Global Dividend .. 2.06 % 0.00 %

N/A

 N/A
DHS:SW 1.89 % 0.00 %

N/A

 N/A
DHSA:SW WisdomTree US Equity Inco.. 1.89 % 0.00 %

+0.54 (+-0.90%)

 N/A
USDV:SW SPDR® S&P US Dividend Ar.. 1.71 % 0.00 %

+0.31 (+-0.90%)

 USD 3.68B
CVMC Morgan Stanley ETF Trust .. 0.51 % 0.00 %

-1.21 (-0.90%)

 N/A
CUD:CA iShares US Dividend Growe.. 0.00 % 0.66 %

-0.13 (-0.90%)

 CAD 0.32B
VSDA VictoryShares Dividend Ac.. 0.00 % 0.35 %

-0.12 (-0.90%)

 USD 0.24B
NEED 0.00 % 0.00 %

N/A

 N/A
RYJ Invesco Raymond James SB-.. 0.00 % 0.75 %

N/A

 N/A
SDY SPDR® S&P Dividend ETF 0.00 % 0.35 %

-0.12 (-0.90%)

 N/A
SDYL 0.00 % 0.00 %

N/A

 N/A
SZK ProShares UltraShort Cons.. 0.00 % 0.95 %

-0.33 (-0.90%)

 USD 0.62M
DHS:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+11.05 (+-0.90%)

 N/A
DHSA:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+0.23 (+-0.90%)

 N/A
DHSD:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+0.16 (+-0.90%)

 N/A
DHSG:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+13.25 (+-0.90%)

 N/A
DHSP:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+13.50 (+-0.90%)

 N/A
UDVD:LSE SPDR® S&P US Dividend Ar.. 0.00 % 0.00 %

+0.33 (+-0.90%)

 USD 3.76B
USDV:LSE SPDR S&P US Dividend Aris.. 0.00 % 0.00 %

+0.23 (+-0.90%)

 USD 3.69B
FLXX:F 0.00 % 0.00 %

N/A

 N/A
SPYD:F 0.00 % 0.00 %

N/A

 N/A
FLXX:XETRA 0.00 % 0.00 %

N/A

 N/A
SPYD:XETRA 0.00 % 0.00 %

N/A

 N/A
SPPD:XETRA 0.00 % 0.00 %

N/A

 N/A
TACE 0.00 % 0.00 %

N/A

 N/A
FUD-A:CA 0.00 % 0.00 %

N/A

 N/A
SPPD:F 0.00 % 0.00 %

N/A

 N/A

Market Performance

  Market Performance vs. Industry/Classification (Household & Personal Products) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.04% 82% B 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.04% 82% B 82% B
Trailing 12 Months  
Capital Gain 15.31% 88% B+ 74% C
Dividend Return 4.01% 100% F 60% D-
Total Return 19.32% 88% B+ 76% C+
Trailing 5 Years  
Capital Gain -0.77% 57% F 46% F
Dividend Return 16.33% 83% B 54% F
Total Return 15.56% 57% F 43% F
Average Annual (5 Year Horizon)  
Capital Gain -0.75% 47% F 27% F
Dividend Return 2.58% 41% F 34% F
Total Return 3.33% 83% B 67% D+
Risk Return Profile  
Volatility (Standard Deviation) 7.59% 100% F 84% B
Risk Adjusted Return 34.03% 47% F 48% F
Market Capitalization 44.91B 92% A 95% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector